Starts 8/31/2021 | Expires 8/31/2022
Clinical Conversations on Diabetes Technology - An AACE Guidelines Update is designed to equip endocrinologists, endocrine care team members, and adult primary care clinicians with evidence-based knowledge and increased competence about how to use diabetes technology and devices to guide and modify treatment approaches for patients with diabetes.
CME Credits:1
MOC Credits:1
Price: Free
Target Audience
This educational initiative is intended for endocrinologists, endocrine care team members, and primary care clinicians who care for patients with diabetes.
Learning Objectives
Through this education, learners will improve their abilities to:
- Review available diabetes technologies to manage persons with diabetes.
- Discuss how CGMs, connected pens, insulin pumps, and integrated devices can be applied in the shared clinical decision-making process to better manage your patients with diabetes.
- Select the appropriate diabetes technologies and devices for the individual patient.
- Incorporate diabetes technologies that are effective in managing your patients in special populations.
Faculty
 |
Matthew J. Levine, MD, FACE |
 |
Lucy H. Thornton, MSN, APRN, FNP-BC |
 |
Sandra Weber, MD, FACE |
 |
Jeffrey R. Unger, MD, FAAFP, FACE |
ACCME
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Endocrinology (ACE) designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.
Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared with the American Board of Internal Medicine (ABIM) through the Accreditation Council for Continuing Medical Education (ACCME) Program and Activity Reporting System (PARS).
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and AACE. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hour.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - JA4008162-9999-21-3003-H01-P)
Type of Activity: Knowledge
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
This activity is supported by independent educational grants from Abbott Diabetes Care, DexCom, Inc., Medtronic, and Novo Nordisk Inc.
The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.
|
Faculty |
Financial Relationships |
Other |
|
Matthew Levine, MD, FACE |
Novo Nordisk: Speakers bureau on diabetes; Eli Lilly: Speakers bureau on diabetes |
CACE Board of Directors (Clinical Association of California Endocrinologists) |
|
Sandra Weber, MD |
NovoNordisk: Research support |
N/A |
|
Jeffrey Unger, MD, FAAFP, FACE |
Abbott Diabetes: Primary Care Advisory Board, Speaker; Dexcom: Primary Care Advisory Board; Medtronic Diabetes: Primary Care Advisory Board
|
N/A |
|
Lucy Thornton, APRN |
N/A |
N/A |